阿尔茨海默病与额颞叶痴呆中糖代谢改变和Aβ沉积与神经递质系统分布相关
本回顾性队列纳入507例受试者(261例AD、111例MCI、62例FTD、73例正常对照),采用18F-FDG PET、18F-AV45 Aβ PET和结构MRI多模态神经影像,结合JuSpace工具箱评估影像改变与神经递质受体/转运体分布的空间共定位。AD糖代谢减低与5-羟色胺能、GABA能、多巴胺能及谷氨酸能系统相关,FTD与5-羟色胺能、多巴胺能及阿片受体相关;Aβ沉积在AD与5HT2a、GABAa及NAT共定位,在MCI与D1受体共定位。
要点
- AD与FTD糖代谢减低分别与不同神经递质系统分布存在空间共定位关系。
- Aβ沉积在AD与5HT2a、GABAa、NAT共定位,在MCI与D1受体共定位。
- AD中FDG或Aβ PET-神经递质相关性与MMSE/MoCA评分显著相关。
核心结论
- AD和FTD在神经递质系统上表现出独特的空间易损性,与糖代谢减低和Aβ病理密切相关。
- 识别疾病特异性神经影像-神经递质特征可推进生物标志物开发,并支持针对分子通路的靶向治疗策略。
研究设计与样本
- 本回顾性队列研究纳入507例受试者,包括261例AD、111例MCI、62例FTD和73例正常对照。
- 受试者接受多模态神经影像检查,包括18F-FDG PET、18F-AV45 Aβ PET和结构MRI。
- 采用JuSpace工具箱评估影像改变与神经递质受体/转运体分布的空间共定位。
- 采用Spearman相关评估影像-神经递质共定位与认知评分的关联。
- 所有分析采用错误发现率(FDR)校正控制P < 0.05。
主要发现
- AD表现为颞顶叶和额叶区域糖代谢减低,FTD表现为额颞叶区域糖代谢减低。
- AD糖代谢减低与5-羟色胺能、γ-氨基丁酸能(GABA能)、多巴胺能及谷氨酸能系统相关。
- FTD糖代谢减低与5-羟色胺能、多巴胺能及阿片受体相关。
- AD中Aβ沉积与5HT2a受体、γ-氨基丁酸A型(GABAa)受体及去甲肾上腺素转运体(NAT)共定位,MCI中Aβ沉积与D1受体共定位。
- AD中FDG或Aβ PET-神经递质相关性与MMSE/MoCA评分显著相关;Aβ-5-羟色胺转运体(SERT)或氟多巴(FDOPA)相关性与Aβ阳性MCI的认知下降相关(P < 0.05)。
关键数值与推荐
- 空间共定位分析显示AD糖代谢减低与5-羟色胺能、GABA能、多巴胺能及谷氨酸能系统相关。
- FTD糖代谢减低与5-羟色胺能、多巴胺能及阿片受体相关。
- AD中Aβ沉积与5HT2a受体、GABAa受体及NAT共定位。
- MCI中Aβ沉积与D1受体共定位。
- AD中FDG或Aβ PET-神经递质相关性与MMSE/MoCA评分显著相关,Aβ-SERT或FDOPA相关性与Aβ阳性MCI认知下降相关(P < 0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to elucidate the spatial correlations among alterations in glucose metabolism, amyloid-beta (Aβ) deposition, and neurotransmitter systems across Alzheimer's disease (AD), mild cognitive impairment (MCI) and frontotemporal dementia (FTD), while assessing their associations with clinical cognitive decline. METHODS: In this retrospective cohort study, 507 participants (261 AD, 111 MCI, 62 FTD and 73 normal controls) underwent multimodal neuroimaging, including 18F-FDG PET, 18F-AV45 Aβ PET, and structural MRI. Spatial co-localization of imaging alterations with neurotransmitter receptor/transporter distributions was assessed using the JuSpace toolbox. Spearman correlations evaluated associations between imaging-neurotransmitter co-localization and cognitive scores. False discovery rate (FDR) correction was used to control for P < 0.05 for all analyses. RESULTS: AD showed glucose hypometabolism in temporoparietal and frontal regions, while FTD was observed in the frontotemporal areas. Spatial co-localization analyses revealed subtype-specific neurotransmitter vulnerabilities: AD glucose hypometabolism correlated with serotonergic, γ-aminobutyric acidergic (GABAergic), dopaminergic, and glutamatergic systems, while FTD correlated with serotonergic, dopaminergic, and opioid receptors. Aβ deposition co-localized with 5HT2a receptor, γ-aminobutyric acid type A (GABAa) receptors, and noradrenaline transporter (NAT) in AD, as well as D1 receptor in MCI. In AD, FDG or Aβ PET-neurotransmitter correlations significantly associated with MMSE/MoCA scores, while Aβ-serotonin transporter (SERT) or Fluorodopa (FDOPA) correlations linked to cognitive decline in Aβ-positive MCI (P < 0.05). CONCLUSION: This study demonstrates that AD and FTD exhibit unique spatial vulnerabilities in neurotransmitter systems, closely tied to glucose hypometabolism and Aβ pathology. The identification of disease specific neuroimaging-neurotransmitter signatures advances biomarker development and supports targeted therapeutic strategies tailored to molecular pathways. CLINICAL TRIAL NUMBER: not applicable. 1. Decreased glucose metabolism in AD and FTD has spatial localization relationship with different neurotransmitter systems.2. Aβ deposition has a co-localization relationship with 5HT2a, GABAa, NAT, and D1 distribution in AD or MCI.3. In AD, FDG or Aβ PET-neurotransmitter correlations significantly associated with MMSE/MoCA scores, while Aβ PET-SERT or FDOPA correlations linked to cognitive decline in Aβ-positive MCI.
引用
- Bi S, Chen Z, Li Y, et al. Glucose metabolism alterations and Aβ deposition in AD and FTD are related to the distribution of neurotransmitter systems. Eur J Nucl Med Mol Imaging. 2025. PMID: 40773016. doi:10.1007/s00259-025-07485-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。